CN112641859A - Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof - Google Patents

Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof Download PDF

Info

Publication number
CN112641859A
CN112641859A CN202011101296.8A CN202011101296A CN112641859A CN 112641859 A CN112641859 A CN 112641859A CN 202011101296 A CN202011101296 A CN 202011101296A CN 112641859 A CN112641859 A CN 112641859A
Authority
CN
China
Prior art keywords
blood
weight ratios
dragon
frankincense
myrrh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011101296.8A
Other languages
Chinese (zh)
Inventor
郭淑一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202011101296.8A priority Critical patent/CN112641859A/en
Publication of CN112641859A publication Critical patent/CN112641859A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/37Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/324Boswellia, e.g. frankincense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716Clematis (leather flower)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The invention discloses an analgesic plaster for promoting blood circulation to remove blood stasis, which comprises the following components: 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of radix aconiti agrestis, 1 part of rhizoma corydalis, 1 part of rhizoma ligustici wallichii, 1 part of safflower and 1 part of sesame oil, wherein the tripterygium wilfordii, the frankincense, the myrrh, the radix clematidis, the dragon's blood, the radix aconiti agrestis, the rhizoma corydalis, the: preparing materials, screening the materials, proportioning the materials and mixing the materials to gradually prepare the product. The invention has the advantages of low cost, no pungent smell and little damage when contacting the skin, is used for conservative treatment of various fractures, lumbar muscle strain pain, joint ligament injury and various pain symptoms after trauma, has the effects of promoting blood circulation to remove blood stasis, relieving pain, clearing and activating the channels and collaterals and promoting bone healing, and has certain treatment effect on rheumatoid arthritis.

Description

Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof
Technical Field
The invention mainly relates to the technical field of medical medicines, in particular to a blood circulation promoting, blood stasis removing and pain relieving ointment and a preparation method thereof.
Background
The plaster is a common external application medicine, the plaster plays a role through skin, the plaster therapy is one of the common external treatment methods in the clinical traditional Chinese medicine, the plaster fully mobilizes the efficiency of mutual coordination of the medicines according to the principles of dialectical treatment and the efficacy, the main treatment and the meridian tropism of the traditional Chinese medicine to form a compound of a plurality of medicines, and the effect of mutual coordination of the medicines is utilized to form a large compound of a plurality of medicines so as to play the good effect of the medicines.
According to the musk blood circulation promoting and stasis removing paste and the hot press forming method thereof provided by the patent document with the publication number of CN110075200A, the musk blood circulation promoting and stasis removing paste comprises the following components in parts by weight: 1-3 parts of artificial musk, 8-12 parts of boric acid, 5-8 parts of camphor, 30-35 parts of dragon's blood, 15-20 parts of urea, 110-120 parts of belladonna fluid extract, 4-7 parts of diphenhydramine hydrochloride, 10-14 parts of procaine hydrochloride, 400-500 parts of blood-activating and stasis-removing extract, 2000-2100 parts of rubber, 900-1000 parts of rosin, 2600-2700 parts of zinc oxide, 210-230 parts of wool fat, 90-110 parts of vaseline and 260-280 parts of 95% ethanol. The hot pressing method comprises the steps of rubber cutting, rubber mixing, kneading, filtering, rubber drying and rubber coating.
The above patent documents use a wide variety of material components, which increase the pharmaceutical cost, and the excessive chemical drug components not only cause a sharp odor, but also cause a bad irritating contact with the skin of the patient when applied to the wound site of the patient, resulting in a feeling of discomfort for the patient.
Disclosure of Invention
The invention mainly provides a blood circulation promoting, blood stasis removing and pain relieving plaster and a preparation method thereof, which are used for solving the technical problems in the background technology.
The technical scheme adopted by the invention for solving the technical problems is as follows:
an analgesic plaster for promoting blood circulation to remove blood stasis, which comprises the following components: 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of radix aconiti agrestis, 1 part of rhizoma corydalis, 1 part of rhizoma ligustici wallichii, 1 part of safflower and 1 part of sesame oil, wherein the tripterygium wilfordii, the frankincense, the myrrh, the radix clematidis, the dragon's blood, the radix aconiti agresti;
the weight of each part of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower contained in the analgesic plaster is 5-10 g;
the proportion weight of each part of the clematis root, the monkshood and the kusnezoff monkshood root contained in each part of the sufficient pain relieving plaster is 10-15 g;
the proportion weight of each part of the corydalis tuber contained in each part of the sufficient analgesic plaster is 15-20 g;
the weight of each part of sesame oil contained in the pain relieving ointment in a sufficient amount is 30-40 g.
Further, when the proportioning weight of each part of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii and safflower is 5g, the proportioning weight of each part of clematis root, monkshood and kusnezoff monkshood root is 10g, the proportioning weight of each part of corydalis tuber is 15g, and the proportioning weight of each part of sesame oil is 30 g.
Further, when the mixture ratio of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part is 6g, the mixture ratio of the clematis chinensis, the monkshood and the kusnezoff monkshood in each part is 11g, the mixture ratio of the corydalis tuber in each part is 16g, and the mixture ratio of the sesame oil in each part is 32 g.
Further, when the weight of each part of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii and safflower is 7g, the weight of each part of clematis chinensis, monkshood and kusnezoff monkshood is 12g, the weight of each part of corydalis tuber is 17g, and the weight of each part of sesame oil is 34 g.
Further, when the weight of each part of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii and safflower is 8g, the weight of each part of clematis chinensis, monkshood and kusnezoff monkshood is 13g, the weight of each part of corydalis tuber is 18g, and the weight of each part of sesame oil is 36 g.
Further, when the proportioning weight of each part of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii and safflower is 9g, the proportioning weight of each part of clematis root, monkshood and kusnezoff monkshood root is 14g, the proportioning weight of each part of corydalis tuber is 19g, and the proportioning weight of each part of sesame oil is 38 g.
Further, when the weight ratio of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part is 10g, the weight ratio of the clematis chinensis, the monkshood and the kusnezoff monkshood in each part is 15g, the weight ratio of the corydalis tuber in each part is 20g, and the weight ratio of the sesame oil in each part is 40 g.
According to the technical scheme, the preparation method of the blood circulation promoting, blood stasis removing and pain relieving paste comprises the following specific steps:
sp1, preparing materials, grinding 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of monkshood, 1 part of radix aconiti agrestis, 1 part of corydalis tuber, 1 part of ligusticum wallichii and 1 part of safflower into powder, and preparing 1 part of sesame oil;
sp2, sieving materials, sieving powdered radix Tripterygii Wilfordii, Olibanum, Myrrha, radix Clematidis, sanguis Draxonis, radix Aconiti Kusnezoffii, rhizoma corydalis, rhizoma Ligustici Chuanxiong, and Carthami flos one by one through a sieve of at least 80 meshes;
sp3, weighing the sieved powders of radix Tripterygii Wilfordii, Olibanum, Myrrha, sanguis Draxonis, rhizoma Chuanxiong, flos Carthami, radix Clematidis, radix Aconiti Kusnezoffii, rhizoma corydalis, and oleum sesami respectively;
sp4, mixing the materials, using sesame oil with required weight ratio as mixing medium, pouring the powder of tripterygium wilfordii, frankincense, myrrh, dragon's blood, Ligusticum wallichii, safflower, Clematis chinensis, Sichuan aconite root, wild aconite root, corydalis tuber with sesame oil with required weight ratio into mixing equipment to mix, controlling the mixing temperature between 50-70 deg.C, mixing time 25-30 minutes, and finally waiting for cooling to make the mixture into paste.
Compared with the prior art, the invention has the beneficial effects that:
the invention adopts sesame oil as a mixing medium, and is matched with Chinese medicinal material powders of tripterygium wilfordii, frankincense, myrrh, clematis root, dragon's blood, monkshood, kusnezoff monkshood root, corydalis tuber, Szechuan lovage rhizome, safflower and the like to be mixed to form a paste medicament, has the advantages of low cost, no pungent smell and small injury when contacting the skin, is used for treating various conservative treatments of fracture, lumbar muscle strain pain, joint ligament injury and various pain symptoms after trauma, and has the effects of activating blood circulation to dissipate blood stasis, relieving pain, clearing and activating the channels and collaterals and promoting the.
The present invention will be explained in detail below with reference to specific examples.
Detailed Description
In order to facilitate an understanding of the invention, the invention will now be described more fully hereinafter with reference to the accompanying examples, which may be embodied in different forms and not limited to the examples described herein, but are provided so as to provide a more thorough and complete disclosure of the invention.
It will be understood that when an element is referred to as being "secured to" another element, it can be directly on the other element or intervening elements may be present, and when an element is referred to as being "connected" to another element, it can be directly connected to the other element or intervening elements may also be present, as the terms "vertical", "horizontal", "left", "right" and the like are used herein for descriptive purposes only.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, and the knowledge of the terms used herein in the specification of the present invention is for the purpose of describing particular embodiments and is not intended to limit the present invention, and the term "and/or" as used herein includes any and all combinations of one or more of the associated listed items.
In an embodiment, an analgesic plaster for promoting blood circulation to remove blood stasis comprises the following components: 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of radix aconiti agrestis, 1 part of rhizoma corydalis, 1 part of rhizoma ligustici wallichii, 1 part of safflower and 1 part of sesame oil, wherein the tripterygium wilfordii, the frankincense, the myrrh, the radix clematidis, the dragon's blood, the radix aconiti agresti;
the weight of each part of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower contained in the analgesic plaster is 5-10 g;
the proportion weight of each part of the clematis root, the monkshood and the kusnezoff monkshood root contained in each part of the sufficient pain relieving plaster is 10-15 g;
the proportion weight of each part of the corydalis tuber contained in each part of the sufficient analgesic plaster is 15-20 g;
the weight of each part of sesame oil contained in the pain relieving ointment in a sufficient amount is 30-40 g.
Specifically, when the mixture ratio of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part is 5g, the mixture ratio of the clematis chinensis, the monkshood and the kusnezoff monkshood in each part is 10g, the mixture ratio of the corydalis tuber in each part is 15g, and the mixture ratio of the sesame oil in each part is 30g, the ointment is suitable for patients with slight pain symptoms, and the ointment is represented as shown in table 1,
Figure BDA0002725445760000061
TABLE 1
Specifically, when the mixture ratio of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part is 6g, the mixture ratio of the clematis root, the monkshood and the kusnezoff monkshood root in each part is 11g, the mixture ratio of the corydalis tuber in each part is 16g, and the mixture ratio of the sesame oil in each part is 32g, the ointment is suitable for patients with slight or conventional pain symptoms, and the manifestations are shown in table 2,
Figure BDA0002725445760000071
TABLE 2
Specifically, when the proportioning weight of each part of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii and safflower is 7g, the proportioning weight of each part of clematis root, monkshood and kusnezoff monkshood root is 12g, the proportioning weight of each part of corydalis tuber is 17g, the proportioning weight of each part of sesame oil is 34g, the Chinese medicinal composition is suitable for patients with conventional pain symptoms, and is represented as shown in table 3,
Figure BDA0002725445760000072
Figure BDA0002725445760000081
TABLE 3
Specifically, when the weight ratios of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part are all 8g, the weight ratios of the clematis root, the monkshood and the kusnezoff monkshood root in each part are all 13g, the weight ratio of the corydalis tuber in each part is 18g, and the weight ratio of the sesame oil in each part is 36g, the ointment is suitable for patients with severe pain symptoms, and the ointment is shown in table 4,
Figure BDA0002725445760000082
Figure BDA0002725445760000091
TABLE 4
Specifically, when the weight ratios of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part are 9g, the weight ratios of the clematis chinensis, the monkshood and the kusnezoff monkshood in each part are 14g, the weight ratios of the corydalis tuber in each part are 19g, and the weight ratios of the sesame oil in each part are 38g, the ointment is suitable for patients with severe pain symptoms, and the ointment is shown in table 5,
Figure BDA0002725445760000092
Figure BDA0002725445760000101
TABLE 5
Specifically, when the weight ratios of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower in each part are 10g, the weight ratios of the clematis chinensis, the monkshood and the kusnezoff monkshood in each part are 15g, the weight ratios of the corydalis tuber in each part are 20g, and the weight ratios of the sesame oil in each part are 40g, the ointment is suitable for patients with severe pain symptoms, and the ointment is shown in table 6,
Figure BDA0002725445760000102
TABLE 6
In conclusion, the embodiment proves that the medicine is used for treating various conservative treatments of bone fracture, lumbar muscle strain pain, joint and ligament injury and various pain symptoms after trauma, has the effects of promoting blood circulation to remove blood stasis, relieving pain, clearing and activating the channels and collaterals and promoting bone growth and healing, and in the treatment process, each treatment course is 10 days, one medicine is replaced every day, and the treatment effect is optimal.
In addition, the embodiment content is combined, and a manufacturing method of the blood circulation promoting, blood stasis removing and pain relieving paste is further provided, which comprises the following specific steps:
firstly, preparing materials, namely grinding 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of monkshood, 1 part of radix aconiti agrestis, 1 part of corydalis tuber, 1 part of ligusticum wallichii and 1 part of safflower into powder, and preparing 1 part of sesame oil;
secondly, screening the materials, namely screening the powdery tripterygium wilfordii, the frankincense, the myrrh, the clematis root, the dragon blood, the monkshood, the kusnezoff monkshood root, the corydalis tuber, the ligusticum wallichii and the safflower by a screen mesh one by one, wherein the screen mesh is at least 80 meshes;
thirdly, proportioning materials, namely weighing the screened tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii, safflower, clematis root, monkshood, kusnezoff monkshood root, corydalis tuber and the sesame oil respectively according to corresponding proportioning weights by a weighing device, wherein the weighing device can adopt a conventional special medicine proportioning scale, and the weight precision requirement is +/-0.1-0.5 g;
and fourthly, mixing the materials, namely taking sesame oil with the required proportioning weight as a mixing medium, pouring the powder of tripterygium wilfordii, frankincense, myrrh, dragon's blood, ligusticum wallichii, safflower, clematis root, monkshood, kusnezoff monkshood root, corydalis tuber and the like with the required proportioning weight and the sesame oil into mixing equipment for mixing, controlling the mixing temperature to be 50-70 ℃, mixing for 25-30 minutes, and finally waiting for cooling to enable the mixture to be pasty, wherein the mixing equipment can adopt a paste making machine with the model of YB-400L.
The present invention has been described in connection with the embodiments by way of example, and it is to be understood that the invention is not limited to the specific embodiments described above, and that the invention is within the scope of the invention, as long as the insubstantial modifications of the inventive method concepts and solutions are employed, or the inventive concepts and solutions are directly applied to other applications without modification.

Claims (8)

1. An analgesic plaster for promoting blood circulation to remove blood stasis, which is characterized by comprising the following components: 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of radix aconiti agrestis, 1 part of rhizoma corydalis, 1 part of rhizoma ligustici wallichii, 1 part of safflower and 1 part of sesame oil, wherein the tripterygium wilfordii, the frankincense, the myrrh, the radix clematidis, the dragon's blood, the radix aconiti agresti;
the weight of each part of the tripterygium wilfordii, the frankincense, the myrrh, the dragon's blood, the ligusticum wallichii and the safflower contained in the analgesic plaster is 5-10 g;
the proportion weight of each part of the clematis root, the monkshood and the kusnezoff monkshood root contained in each part of the sufficient pain relieving plaster is 10-15 g;
the proportion weight of each part of the corydalis tuber contained in each part of the sufficient analgesic plaster is 15-20 g;
the weight of each part of sesame oil contained in the pain relieving ointment in a sufficient amount is 30-40 g.
2. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower are 5g, the weight ratios of clematis root, monkshood and kusnezoff monkshood root are 10g, the weight ratios of corydalis tuber are 15g and the weight ratios of sesame oil are 30 g.
3. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower are 6g, the weight ratios of clematis root, monkshood and kusnezoff monkshood root are 11g, the weight ratios of corydalis tuber are 16g and the weight ratios of sesame oil are 32 g.
4. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower are all 7g, the weight ratios of clematis root, monkshood and kusnezoff monkshood root are all 12g, the weight ratio of corydalis tuber is 17g, and the weight ratio of sesame oil is 34 g.
5. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower in each part are 8g, the weight ratios of clematis chinensis, monkshood and kusnezoff monkshood root in each part are 13g, the weight ratio of corydalis tuber in each part is 18g, and the weight ratio of sesame oil in each part is 36 g.
6. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower in each part are 9g, the weight ratios of clematis chinensis, monkshood and kusnezoff monkshood root in each part are 14g, the weight ratios of corydalis tuber in each part are 19g, and the weight ratios of sesame oil in each part are 38 g.
7. The ointment of claim 1, wherein when the weight ratios of tripterygium wilfordii, frankincense, myrrh, dragon's blood, chuanxiong rhizome and safflower are 10g, the weight ratios of clematis root, monkshood and kusnezoff monkshood root are 15g, the weight ratios of corydalis tuber are 20g and the weight ratios of sesame oil are 40 g.
8. The method for preparing the paste of activating blood circulation to dissipate blood stasis and relieving pain of claim 1, comprising the following steps:
sp1, preparing materials, grinding 1 part of tripterygium wilfordii, 1 part of frankincense, 1 part of myrrh, 1 part of radix clematidis, 1 part of dragon's blood, 1 part of monkshood, 1 part of radix aconiti agrestis, 1 part of corydalis tuber, 1 part of ligusticum wallichii and 1 part of safflower into powder, and preparing 1 part of sesame oil;
sp2, sieving materials, sieving powdered radix Tripterygii Wilfordii, Olibanum, Myrrha, radix Clematidis, sanguis Draxonis, radix Aconiti Kusnezoffii, rhizoma corydalis, rhizoma Ligustici Chuanxiong, and Carthami flos one by one through a sieve of at least 80 meshes;
sp3, weighing the sieved powders of radix Tripterygii Wilfordii, Olibanum, Myrrha, sanguis Draxonis, rhizoma Chuanxiong, flos Carthami, radix Clematidis, radix Aconiti Kusnezoffii, rhizoma corydalis, and oleum sesami respectively;
sp4, mixing the materials, using sesame oil with required weight ratio as mixing medium, pouring the powder of tripterygium wilfordii, frankincense, myrrh, dragon's blood, Ligusticum wallichii, safflower, Clematis chinensis, Sichuan aconite root, wild aconite root, corydalis tuber with sesame oil with required weight ratio into mixing equipment to mix, controlling the mixing temperature between 50-70 deg.C, mixing time 25-30 minutes, and finally waiting for cooling to make the mixture into paste.
CN202011101296.8A 2020-10-15 2020-10-15 Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof Pending CN112641859A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011101296.8A CN112641859A (en) 2020-10-15 2020-10-15 Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011101296.8A CN112641859A (en) 2020-10-15 2020-10-15 Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112641859A true CN112641859A (en) 2021-04-13

Family

ID=75346905

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011101296.8A Pending CN112641859A (en) 2020-10-15 2020-10-15 Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112641859A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115487230A (en) * 2022-10-17 2022-12-20 杭州零零医科技有限公司 A topical Chinese medicinal composition for promoting blood circulation, dredging collaterals, warming channels and relieving pain, and its preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
杜杰等: "综合疗法治疗飞行员颈腰腿痛疗效观察", 《人民军医》 *
相跃峰等: "中西医结合治疗腰椎间盘突出症268例报告", 《实用医技杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115487230A (en) * 2022-10-17 2022-12-20 杭州零零医科技有限公司 A topical Chinese medicinal composition for promoting blood circulation, dredging collaterals, warming channels and relieving pain, and its preparation method

Similar Documents

Publication Publication Date Title
WO2013048235A2 (en) A medicinal herbal ointment
CN101912575B (en) External medicament for treating painful swelling of joints and gout diseases and preparation process thereof
CN112641859A (en) Blood circulation promoting, blood stasis removing and pain relieving ointment and preparation method thereof
CN107184782A (en) External medicine composition, preparation method and applications
CN1318065C (en) Externally applied paste for treating soft tissue injury
CN1314441C (en) Plaster for relaxing the muscles and joints and its prepn process
CN1857504A (en) Externally applied medicine for treating acute eczema and its preparing method
CN101249184B (en) Medicine for treating osteoproliferation as well as its preparation method
CN107998192B (en) Traditional Chinese medicine plaster for treating rheumatic diseases based on seaweed carbon fibers and preparation method thereof
CN105616669A (en) Traditional Chinese medicine preparation for treating traumatic injury, soft tissue injury and bone fracture and preparation method of traditional Chinese medicine preparation
CN102247533A (en) External drug for treating trauma
CN111067985A (en) External traditional Chinese medicine composition and traditional Chinese medicine plaster for easing pain as well as preparation method and application
CN111789929A (en) Navel warming plaster
CN104138523A (en) Chinese medicinal composition for treatment of lumbar disc herniation and lumbar vertebra hyperosteogeny and preparation method thereof
CN1082427A (en) Universal incised wound oil and preparation method thereof
Shinde et al. Pharmaceutical study of Vasa (Adhatoda vasica Linn.) With special reference to its different dosage forms
CN1060388C (en) Ointment for treating spur and its preparation method
Singh et al. A Critical Review on Bilwadi Agada
CN117018146A (en) Traditional Chinese medicine composition for treating acute soft tissue injury, preparation and preparation method
CN114762719A (en) Traditional Chinese medicine composition for relaxing tendons and activating collaterals and preparation method thereof
CN111150819A (en) Inflammation-diminishing and pain-relieving ointment for bone fracture and preparation method thereof
CN1068789C (en) Tuberculosis treating medicine and its compounding process
CN114404507A (en) External application liquid medicine for relieving bone injury pain and preparation method thereof
EP4058039A1 (en) Homeopathic topical composition
CN112618671A (en) Traditional Chinese medicine composition for treating lumbar disc herniation, preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20210413